---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-016891"
form_type: "8-K"
ticker: "SINT"
cik: "0001269026"
company_name: "Sintx Technologies, Inc."
filed_at: "2025-06-27T23:59:59+00:00"
generated_at: "2026-05-18T15:33:20.860512+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# SINTX acquires SiNAPTIC Surgical assets for $750K in stock plus warrants; enters foot/ankle fusion market

## Summary
- Acquired all IP and designs for six foot/ankle implant systems; market valued at $750M growing to $1.38B by 2032.
- Consideration: $750K in common shares at $3.465 (10% premium) plus 325,000 performance-based warrants exercisable at $6.30.
- Warrants vest upon FDA clearance and cumulative revenue milestones up to $15M; also 5% royalty after $15M.
- Key SiNAPTIC executives join SINTX: Dr. Bryan Scheer leads Clinical Advisory Board, plus others in commercial and regulatory roles.
- Expected closing July 1, 2025; SINTX will manufacture under its existing FDA-registered and ISO-certified quality system.

## SEC filing metadata
- accession: 0001641172-25-016891
- form_type: 8-K
- ticker: SINT
- cik: 0001269026
- company_name: Sintx Technologies, Inc.
- filed_at: 2025-06-27T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1269026/000164117225016891/0001641172-25-016891-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1269026/000164117225016891/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-016891
- JSON: https://secwatch.observer/filing/0001641172-25-016891.json
- Plain text: https://secwatch.observer/filing/0001641172-25-016891.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.